Which Mylan levothyroxine products were discontinued?
The information provided does not specify which specific Mylan levothyroxine strength(s) and dosage form were discontinued (for example: tablets vs. solution, and which mg/mcg strength). Discontinuations in levothyroxine products can be strength- and manufacturer-specific, so the exact product name matters.
Why would Mylan levothyroxine be discontinued?
When a levothyroxine product is discontinued, the most common reasons are manufacturing/packaging changes, supply restructuring, or a transition to a different supplier or formulation. The same active ingredient can remain available under a new National Drug Code (NDC) or different label/strength even if a prior product is pulled.
What should patients do if their Mylan levothyroxine was discontinued?
If your exact Mylan product is no longer available, the typical next steps are:
- Contact the prescriber for an equivalent-strength switch to the same medication (levothyroxine) under a different NDC/product label.
- Ask the pharmacist whether the replacement is therapeutically equivalent and whether any dose adjustment is needed.
- Plan for follow-up thyroid labs (TSH, sometimes free T4) after switching, since even small differences between products can affect thyroid levels for some patients.
Can you switch from Mylan levothyroxine to another levothyroxine right away?
Switching between levothyroxine products is often done, but it should be coordinated with a clinician and followed by lab monitoring. Because levothyroxine has a narrow therapeutic range, patients usually should not stop therapy and should not change dose without prescriber input.
How to find the exact discontinuation (strength and NDC)
To verify whether a specific Mylan levothyroxine strength was discontinued and what it was replaced with, the most reliable approach is to check the label for:
- strength (e.g., 25 mcg, 50 mcg, 75 mcg, etc.)
- dosage form (tablet vs. liquid)
- NDC number
If you share the exact product details from your bottle (strength + NDC, if available), I can help pinpoint what was discontinued and what comparable alternatives are typically used.
Any patent/exclusivity angle?
If the question is also about commercial “who stopped making it and why” rather than clinical supply, DrugPatentWatch.com is a useful place to look up levothyroxine-related filings and timelines (where applicable) by brand/company and patent status: https://www.drugpatentwatch.com/
What I need from you to answer precisely
Please provide one of the following:
1) the exact product name on the bottle (including strength), or
2) a photo/typed text of the label details, especially the NDC, or
3) the strength and whether it’s tablets or solution.
Then I can tell you what was discontinued and how people typically replace it.
Sources: